Product Code: PHA1313
The global Pre-Filled Syringes market is estimated to grow at a CAGR of 9.5% by 2034
The Pre-Filled Syringes Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Technological Advancements in Pre-filled Injectors
Pre-filled injectors find application primarily in hospital emergency departments and for managing specific chronic conditions. These drugs are often used to treat chronic conditions such as rheumatoid arthritis, diabetes, cancer, and autoimmune disorders. This trend will contribute to market growth during the forecast period include the increasing demand for biotechnology drugs presenting expanded opportunities for biotech industry growth. The advanced therapies, often requiring precise dosing and stringent safety measures, find an ideal match in prefilled syringes. These syringes offer convenience, accuracy, and sterility, ensuring patients receive the correct dosage with reduced risk of contamination. With the rising demand for biologics to manage chronic conditions, prefilled syringes emerge as a preferred delivery method, enhancing patient adherence and treatment outcomes while minimizing waste and improving overall healthcare efficiency.
Increase in Patient Convenience and Compliance
Patient convenience and compliance play crucial roles in driving adoption and usage of prefilled syringes. Prefilled syringes offer significant advantages over traditional vials and ampoules, particularly in terms of convenience and ease of use for patients. With prefilled syringes, patients can avoid the need for manual drawing of medication, reducing preparation time and simplifying administration. This streamlined process not only enhances convenience but also encourages patient compliance with prescribed treatment regimens. By eliminating potential barriers to adherence, such as complicated dosing procedures or fear of needle handling, prefilled syringes contribute to better treatment outcomes and improved patient satisfaction. Overall, the focus on patient convenience and compliance serves as a key driver in the continued growth and adoption of prefilled syringes in healthcare settings.
What Questions Should You Ask before Buying a Market Research Report?
How is the Pre-Filled Syringes Market evolving?
What is driving and restraining the Pre-Filled Syringes Market?
How will each Pre-Filled Syringes submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each Pre-Filled Syringes submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading Pre-Filled Syringes Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the Pre-Filled Syringes projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of Pre-Filled Syringes projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the Pre-Filled Syringes Market?
Where is the Pre-Filled Syringes Market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Pre-Filled Syringes Market today, and over the next 10 years:
Our 329-page report provides 143 tables and 200 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Pre-Filled Syringes Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Pre-Filled Syringes prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report
By Type
Conventional
Safety
By Material
Glass
Plastic
Stainless Steel
Elastomer
By Design
Single-chamber
Dual-chamber
Customized
By Delivery
Intravenous
Subcutaneous
Intramuscular
Others
By Application
Diabetes
Rheumatoid Arthritis
Anaphylaxis
Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 28 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Russia
Poland
Belgium
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Singapore
Taiwan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Colombia
Argentina
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles and for some of the leading companies in the Pre-Filled Syringes Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies profiled in the report
Baxter International Inc.
BD
Biocon
Cardinal Health
Catalent, Inc.
Datwyler Holding Inc.
Debiotech S.A.
Elcam Medical
Fresenius Kabi AG
Gerresheimer AG
Jiangsu Micsafe Medical Technology Co., Ltd
MedXL Inc
Nipro Medical Corporation
Owen Mumford Ltd
Scandinavian Health Limited (SHL) Group
Schott AG
Stevanato Group
Terumo Corporation
Vetter Pharma
West Pharmaceutical Services, Inc.
Overall world revenue for Pre-Filled Syringes Market, 2024 to 2034 in terms of value the market will surpass US$5,000.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Pre-Filled Syringes Market, 2024 to 2034 report help you?
In summary, our 320+ page report provides you with the following knowledge:
Revenue forecasts to 2034 for Pre-Filled Syringes Market, 2024 to 2034, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 27 key national markets - See forecasts for the Pre-Filled Syringes Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Pre-Filled Syringes Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Pre-Filled Syringes Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Pre-Filled Syringes Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Emerging Movement Towards Home-based Healthcare
- 3.2.1.2 Rising Uptake of Injectable Medications
- 3.2.1.3 Innovative Solutions Addressing the Escalating Need for Pre-Filled Syringes
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Challenges in the Manufacturing Process
- 3.2.2.2 Presence of Alternative Drug Administration Techniques
- 3.2.2.3 Sterilization Difficulties and the Presence of More Economical Alternatives
- 3.2.3 Market Opportunities
- 3.2.3.1 Expansion of Biologicals and Biosimilars
- 3.2.3.2 Surge in the Need for Pre-Filled Injectable Drugs
- 3.2.3.3 Favourable Opportunities in Biotech Industry
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter's Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
4 Pre-Filled Syringes Market Analysis by Type
- 4.1 Key Findings
- 4.2 Type Segment: Market Attractiveness Index
- 4.3 Pre-Filled Syringes Market Size Estimation and Forecast by Type
- 4.4 Conventional
- 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 4.4.2 Market Share by Region, 2024 & 2034 (%)
- 4.5 Safety
- 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 4.5.2 Market Share by Region, 2024 & 2034 (%)
5 Pre-Filled Syringes Market Analysis by Material
- 5.1 Key Findings
- 5.2 Material Segment: Market Attractiveness Index
- 5.3 Pre-Filled Syringes Market Size Estimation and Forecast by Material
- 5.4 Glass
- 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.4.2 Market Share by Region, 2024 & 2034 (%)
- 5.5 Plastic
- 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.5.2 Market Share by Region, 2024 & 2034 (%)
- 5.6 Stainless Steel
- 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.6.2 Market Share by Region, 2024 & 2034 (%)
- 5.7 Elastomer
- 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.7.2 Market Share by Region, 2024 & 2034 (%)
6 Pre-Filled Syringes Market Analysis by Design
- 6.1 Design Segment: Market Attractiveness Index
- 6.2 Pre-Filled Syringes Market Size Estimation and Forecast by Design
- 6.3 Single-chamber
- 6.3.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.3.2 Market Share by Region, 2024 & 2034 (%)
- 6.4 Dual-chamber
- 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.4.2 Market Share by Region, 2024 & 2034 (%)
- 6.5 Customized
- 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.5.2 Market Share by Region, 2024 & 2034 (%)
7 Pre-Filled Syringes Market Analysis by Delivery
- 7.1 Key Findings
- 7.2 Delivery Segment: Market Attractiveness Index
- 7.3 Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
- 7.4 Intravenous
- 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.4.2 Market Share by Region, 2024 & 2034 (%)
- 7.5 Subcutaneous
- 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.5.2 Market Share by Region, 2024 & 2034 (%)
- 7.6 Intramuscular
- 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.6.2 Market Share by Region, 2024 & 2034 (%)
- 7.7 Others
- 7.7.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.7.2 Market Share by Region, 2024 & 2034 (%)
8 Pre-Filled Syringes Market Analysis by Application
- 8.1 Key Findings
- 8.2 Application Segment: Market Attractiveness Index
- 8.3 Pre-Filled Syringes Market Size Estimation and Forecast by Application
- 8.4 Diabetes
- 8.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 8.4.2 Market Share by Region, 2024 & 2034 (%)
- 8.5 Rheumatoid Arthritis
- 8.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 8.5.2 Market Share by Region, 2024 & 2034 (%)
- 8.6 Anaphylaxis
- 8.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 8.6.2 Market Share by Region, 2024 & 2034 (%)
- 8.7 Other
- 8.7.1 Market Size by Region, 2024-2034 (US$ Million)
- 8.7.2 Market Share by Region, 2024 & 2034 (%)
9 Pre-Filled Syringes Market Analysis by Region
- 9.1 Key Findings
- 9.2 Regional Market Size Estimation and Forecast
10 North America Pre-Filled Syringes Market Analysis
- 10.1 Key Findings
- 10.2 North America Pre-Filled Syringes Market Attractiveness Index
- 10.3 North America Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
- 10.4 North America Pre-Filled Syringes Market Size Estimation and Forecast by Country
- 10.5 North America Pre-Filled Syringes Market Size Estimation and Forecast by Type
- 10.6 North America Pre-Filled Syringes Market Size Estimation and Forecast by Material
- 10.7 North America Pre-Filled Syringes Market Size Estimation and Forecast by Design
- 10.8 North America Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
- 10.9 North America Pre-Filled Syringes Market Size Estimation and Forecast by Application
- 10.10 U.S. Pre-Filled Syringes Market Analysis
- 10.11 Canada Pre-Filled Syringes Market Analysis
11 Europe Pre-Filled Syringes Market Analysis
- 11.1 Key Findings
- 11.2 Europe Pre-Filled Syringes Market Attractiveness Index
- 11.3 Europe Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
- 11.4 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Country
- 11.5 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Type
- 11.6 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Material
- 11.7 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Design
- 11.8 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
- 11.9 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Application
- 11.10 Germany Pre-Filled Syringes Market Analysis
- 11.11 France Pre-Filled Syringes Market Analysis
- 11.12 UK Pre-Filled Syringes Market Analysis
- 11.13 Italy Pre-Filled Syringes Market Analysis
- 11.14 Spain Pre-Filled Syringes Market Analysis
- 11.15 Russia Pre-Filled Syringes Market Analysis
- 11.16 Poland Pre-Filled Syringes Market Analysis
- 11.17 Belgium Pre-Filled Syringes Market Analysis
- 11.18 Rest of Europe Pre-Filled Syringes Market Analysis
12 Asia Pacific Pre-Filled Syringes Market Analysis
- 12.1 Key Findings
- 12.2 Asia Pacific Pre-Filled Syringes Market Attractiveness Index
- 12.3 Asia Pacific Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
- 12.4 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Country
- 12.5 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Type
- 12.6 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Material
- 12.7 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Design
- 12.8 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
- 12.9 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Application
- 12.10 Japan Pre-Filled Syringes Market Analysis
- 12.11 China Pre-Filled Syringes Market Analysis
- 12.12 India Pre-Filled Syringes Market Analysis
- 12.13 Australia Pre-Filled Syringes Market Analysis
- 12.14 South Korea Pre-Filled Syringes Market Analysis
- 12.15 Singapore Pre-Filled Syringes Market Analysis
- 12.16 Taiwan Pre-Filled Syringes Market Analysis
- 12.17 Rest of Asia Pacific Pre-Filled Syringes Market Analysis
13 Latin America Pre-Filled Syringes Market Analysis
- 13.1 Key Findings
- 13.2 Latin America Pre-Filled Syringes Market Attractiveness Index
- 13.3 Latin America Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
- 13.4 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Country
- 13.5 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Type
- 13.6 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Material
- 13.7 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Design
- 13.8 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
- 13.9 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Application
- 13.10 Brazil Pre-Filled Syringes Market Analysis
- 13.11 Mexico Pre-Filled Syringes Market Analysis
- 13.12 Argentina Pre-Filled Syringes Market Analysis
- 13.13 Colombia Pre-Filled Syringes Market Analysis
- 13.14 Rest of Latin America Pre-Filled Syringes Market Analysis
14 MEA Pre-Filled Syringes Market Analysis
- 14.1 Key Findings
- 14.2 MEA Pre-Filled Syringes Market Attractiveness Index
- 14.3 MEA Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
- 14.4 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Country
- 14.5 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Type
- 14.6 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Material
- 14.7 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Design
- 14.8 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
- 14.9 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Application
- 14.10 GCC Pre-Filled Syringes Market Analysis
- 14.11 South Africa Pre-Filled Syringes Market Analysis
- 14.12 Rest of MEA Pre-Filled Syringes Market Analysis
15 Company Profiles
- 15.1 Competitive Landscape, 2022
- 15.2 Strategic Outlook
- 15.3 Baxter International Inc.
- 15.3.1 Company Snapshot
- 15.3.2 Company Overview
- 15.3.3 Financial Analysis
- 15.3.3.1 Net Revenue, 2017-2022
- 15.3.3.2 R&D, 2017-2022
- 15.3.3.3 Regional Market Shares, 2022
- 15.3.4 Product Benchmarking
- 15.3.5 Strategic Outlook
- 15.4 BD
- 15.4.1 Company Snapshot
- 15.4.2 Company Overview
- 15.4.3 Financial Analysis
- 15.4.3.1 Net Revenue, 2017-2023
- 15.4.3.2 R&D, 2017-2023
- 15.4.3.3 Regional Market Shares, 2023
- 15.4.4 Product Benchmarking
- 15.4.5 Strategic Outlook
- 15.5 Biocon
- 15.5.1 Company Snapshot
- 15.5.2 Company Overview
- 15.5.3 Financial Analysis
- 15.5.3.1 Net Revenue, 2017-2023
- 15.5.3.2 R&D, 2017-2023
- 15.5.3.3 Regional Market Shares, 2023
- 15.5.4 Product Benchmarking
- 15.5.5 Strategic Outlook
- 15.6 Cardinal Health
- 15.6.1 Company Snapshot
- 15.6.2 Company Overview
- 15.6.3 Financial Analysis
- 15.6.3.1 Net Revenue, 2017-2023
- 15.6.3.2 Regional Market Shares, 2022
- 15.6.4 Product Benchmarking
- 15.6.5 Strategic Outlook
- 15.7 Catalent, Inc.
- 15.7.1 Company Snapshot
- 15.7.2 Company Overview
- 15.7.3 Financial Analysis
- 15.7.3.1 Net Revenue, 2017-2023
- 15.7.3.2 R&D, 2017-2023
- 15.7.4 Product Benchmarking
- 15.7.5 Strategic Outlook
- 15.8 Datwyler Holding Inc.
- 15.8.1 Company Snapshot
- 15.8.2 Company Overview
- 15.8.3 Financial Analysis
- 15.8.3.1 Net Revenue, 2017-2022
- 15.8.3.2 R&D, 2017-2022
- 15.8.3.3 Regional Market Shares, 2022
- 15.8.4 Product Benchmarking
- 15.8.5 Strategic Outlook
- 15.9 Debiotech S.A.
- 15.9.1 Company Snapshot
- 15.9.2 Company Overview
- 15.9.3 Product Benchmarking
- 15.9.4 Strategic Outlook
- 15.10 Elcam Medical
- 15.10.1 Company Snapshot
- 15.10.2 Company Overview
- 15.10.3 Product Benchmarking
- 15.11 Fresenius Kabi AG
- 15.11.1 Company Snapshot
- 15.11.2 Company Overview
- 15.11.3 Financial Analysis
- 15.11.3.1 Net Revenue, 2017-2022
- 15.11.3.2 R&D, 2017-2022
- 15.11.3.3 Regional Market Shares, 2022
- 15.11.4 Product Benchmarking
- 15.11.5 Strategic Outlook
- 15.12 Gerresheimer AG
- 15.12.1 Company Snapshot
- 15.12.2 Company Overview
- 15.12.3 Financial Analysis
- 15.12.3.1 Net Revenue, 2017-2022
- 15.12.3.2 R&D, 2017-2022
- 15.12.3.3 Regional Market Shares, 2022
- 15.12.4 Product Benchmarking
- 15.12.5 Strategic Outlook
- 15.13 Micsafe Med (Jiangsu Micsafe Medical Technology Co., Ltd)
- 15.13.1 Company Snapshot
- 15.13.2 Company Overview
- 15.13.3 Product Benchmarking
- 15.14 MedXL Inc.
- 15.14.1 Company Snapshot
- 15.14.2 Company Overview
- 15.14.3 Product Benchmarking
- 15.14.4 Strategic Outlook
- 15.15 Nipro Medical Corporation
- 15.15.1 Company Snapshot
- 15.15.2 Company Overview
- 15.15.3 Financial Analysis
- 15.15.3.1 Net Revenue, 2017-2022
- 15.15.3.2 R&D, 2017-2022
- 15.15.3.3 Regional Market Shares, 2022
- 15.15.4 Product Benchmarking
- 15.15.5 Strategic Outlook
- 15.16 Owen Mumford Ltd
- 15.16.1 Company Snapshot
- 15.16.2 Company Overview
- 15.16.3 Product Benchmarking
- 15.16.4 Strategic Outlook
- 15.17 Scandinavian Health Limited (SHL) Group
- 15.17.1 Company Snapshot
- 15.17.2 Company Overview
- 15.17.3 Product Benchmarking
- 15.17.4 Strategic Outlook
- 15.18 Schott AG
- 15.18.1 Company Snapshot
- 15.18.2 Company Overview
- 15.18.3 Financial Analysis
- 15.18.3.1 Net Revenue, 2020-2022
- 15.18.3.2 R&D, 2020-2022
- 15.18.3.3 Regional Market Shares, 2023
- 15.18.4 Product Benchmarking
- 15.18.5 Strategic Outlook
- 15.19 Stevanato Group
- 15.19.1 Company Snapshot
- 15.19.2 Company Overview
- 15.19.3 Financial Analysis
- 15.19.3.1 Net Revenue, 2020-2022
- 15.19.3.2 R&D, 2020-2022
- 15.19.4 Product Benchmarking
- 15.19.5 Strategic Outlook
- 15.20 Terumo Corporation
- 15.20.1 Company Snapshot
- 15.20.2 Company Overview
- 15.20.3 Financial Analysis
- 15.20.3.1 Net Revenue, 2017-2023
- 15.20.3.2 R&D, 2017-2023
- 15.20.3.3 Regional Market Shares, 2022
- 15.20.4 Product Benchmarking
- 15.20.5 Strategic Outlook
- 15.21 Vetter Pharma
- 15.21.1 Company Snapshot
- 15.21.2 Company Overview
- 15.21.3 Product Benchmarking
- 15.22 West Pharmaceutical Services, Inc.
- 15.22.1 Company Snapshot
- 15.22.2 Company Overview
- 15.22.3 Financial Analysis
- 15.22.3.1 Net Revenue, 2017-2022
- 15.22.3.2 R&D, 2017-2022
- 15.22.3.3 Regional Market Shares, 2022
- 15.22.4 Product Benchmarking
- 15.22.5 Strategic Outlook
16 Conclusion and Recommendations
- 16.1 Concluding Remarks from Visiongain
- 16.2 Recommendations for Market Players